PRGO News and Press, Perrigo Company plc From 09/08/20

DUBLIN , Sept. 8, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has launched the store brand equivalent of over-the-counter ("OTC") Voltaren ® Arthritis Pain (diclofenac sodium topical gel, 1%) to its retail partners and the produc...

Patent challenge initiated by Bausch Health Companies NESS ZIONA, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug product...

Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...

Perrigo ( PRGO +2.9% ) will acquire three Eastern European OTC skincare and hair loss treatment brands including Emolium, Iwostin and Loxon, from Sanofi, for an undisclosed consideration. More news on: Perrigo Company plc, Merger & acquisition news, Healthcare stocks...

DUBLIN , Aug. 11, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products,  today announced that it will acquire three Eastern European OTC skincare and hair loss treatment brands (Emolium ® , Iw...

New Drug Application for Epsolay® Submitted; Twyneo® New Drug Application on track for 2H 2020 Top-line generic product revenue of $1.1 million in 2Q 2020 Launch of additional generic product expected in 2Q 2021 NESS ZIONA, Israel, Aug. 06, 2020 (GLOBE NEWSWIRE) --...

Perrigo Company plc (PRGO) Q2 2020 Earnings Conference Call August 05, 2020 09:00 AM ET Company Participants Brad Joseph - VP, Global IR and Corporate Communications Murray Kessler - President and Chief Executive Officer Ray Silcock - Chief Financial Officer Conference Call Pa...

Perrigo (NYSE: PRGO ) Q2 results : More news on: Perrigo Company plc Read more ...

The following slide deck was published by Perrigo Company plc in conjunction with their 2020 Q2 earnings Read more ...

Perrigo (NYSE: PRGO ) : Q2 Non-GAAP EPS of $1.03 beats by $0.16 ; GAAP EPS of $0.44 beats by $0.03 . More news on: Perrigo Company plc, Earnings news and commentary, Healthcare stocks news, Read more ...